Navigare Ventures

Elypta is developing a metabolism-based liquid biopsy platform based on a new IVD laboratory assay kit and artificial intelligence algorithms trained by their clinical database. Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment response. They also explore several other indications to understand the full potential for Elypta’s platform.

Peafowl Solar Power AB, founded in 2018 and based in Uppsala, Sweden, specializes in the manufacturing of innovative solar and photovoltaic cells. The company focuses on producing highly transparent, affordable, efficient, and stable solar cells designed to power a variety of devices, including Internet of Things (IoT) applications, sensors, wearables, and smart glasses. Through its advanced technology, Peafowl aims to enhance the energy efficiency and functionality of modern electronic devices.

Elypta is developing a metabolism-based liquid biopsy platform based on a new IVD laboratory assay kit and artificial intelligence algorithms trained by their clinical database. Elypta proudly sponsors the clinical trial series AURORAX to investigate applications in their lead indication renal cell carcinoma from surveillance of recurrence to monitoring treatment response. They also explore several other indications to understand the full potential for Elypta’s platform.